Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma
Cells · 28.03.2023 · 12 (7) · 1030
DOI: 10.3390/cells12071030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 28.03.2023. Verfasst von Shamila D Alipoor und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada. Hauptthemen laut MEDLINE: MicroRNAs, Multiple Myeloma. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leukemia and Lymphoma Society of Canada (LLSC).
Abstract (Originalsprache)
Multiple myeloma (MM) is a malignancy of plasma cells in the bone marrow and is characterized by the clonal proliferation of B-cells producing defective monoclonal immunoglobulins. Despite the latest developments in treatment, drug resistance remains one of the major challenges in the therapy of MM. The crosstalk between MM cells and other components within the bone marrow microenvironment (BME) is the major determinant of disease phenotypes. Exosomes have emerged as the critical drivers of this crosstalk by allowing the delivery of informational cargo comprising multiple components from miniature peptides to nucleic acids. Such material transfers have now been shown to perpetuate drug-resistance development and disease progression in MM. MicroRNAs(miRNAs) specifically play a crucial role in this communication considering their small size that allows them to be readily packed within the exosomes and widespread potency that impacts the developmental trajectory of the disease inside the tumor microenvironment (TME). In this review, we aim to provide an overview of the current understanding of the role of exosomal miRNAs in the epigenetic modifications inside the TME and its pathogenic influence on the developmental phenotypes and prognosis of MM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
- Department of Molecular Medicine, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran P5X9+7F9, Iran.
- Department of Laboratory Hematology, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2M9, Canada.
ORCID-Profile: Shamila D Alipoor
Förderung
- Leukemia and Lymphoma Society of Canada (LLSC)
Zitieren
APA
Alipoor, S. D., & Chang, H. (2023). Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma. Cells, 12(7), 1030. https://doi.org/10.3390/cells12071030
Vancouver
Alipoor SD, Chang H. Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma. Cells. 2023;12(7):1030. doi:10.3390/cells12071030
BibTeX
@article{Alipoor2023,
author = {Alipoor, Shamila D and Chang, Hong},
title = {Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma},
journal = {Cells},
year = {2023},
volume = {12},
number = {7},
pages = {1030},
doi = {10.3390/cells12071030}
}
EUVIMED